IMP
Process View
regulation of protein autophosphorylation
Any process that modulates the frequency, rate or extent of addition of the phosphorylation by a protein of one or more of its own residues.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of protein autophosphorylation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 1.000 | ||
| RAD50 | RAD50 homolog (S. cerevisiae) | 0.980 | ||
| NBN | nibrin | 0.957 | ||
| TOLLIP | toll interacting protein | 0.956 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.956 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.936 | ||
| VEGFA | vascular endothelial growth factor A | 0.821 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.744 | ||
| IER3 | immediate early response 3 | 0.719 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.664 | ||
| H2AFX | H2A histone family, member X | 0.651 | ||
| ATM | ataxia telangiectasia mutated | 0.268 | ||
| BRCA1 | breast cancer 1, early onset | 0.198 | ||
| NRP1 | neuropilin 1 | 0.165 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.146 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.121 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.089 | ||
| PGF | placental growth factor | 0.077 | Human | |
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.065 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.059 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.049 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.048 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.046 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.045 | ||
| SFN | stratifin | 0.039 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.035 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.034 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.034 | ||
| ATRX | alpha thalassemia/mental retardation syndrome X-linked | 0.034 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.033 | ||
| RBBP8 | retinoblastoma binding protein 8 | 0.031 | ||
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | 0.029 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.029 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.027 | ||
| RUNDC3A | RUN domain containing 3A | 0.027 | ||
| RNF8 | ring finger protein 8 | 0.026 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.025 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.025 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.025 | ||
| KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.023 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.021 | ||
| TOM1 | target of myb1 (chicken) | 0.020 | Human | |
| DDIT3 | DNA-damage-inducible transcript 3 | 0.019 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.019 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.018 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.018 | ||
| RAB21 | RAB21, member RAS oncogene family | 0.017 | ||
| RALGDS | ral guanine nucleotide dissociation stimulator | 0.017 | ||
| TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 | 0.017 | ||
| NOMO1 | NODAL modulator 1 | 0.016 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.016 | ||
| EFNA5 | ephrin-A5 | 0.015 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.015 | ||
| PYDC2 | pyrin domain containing 2 | 0.014 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.014 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.014 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.013 | ||
| MUC1 | mucin 1, cell surface associated | 0.013 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.012 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.012 | ||
| CYTB | cytochrome b | 0.012 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.012 | ||
| RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | 0.012 | ||
| IRS2 | insulin receptor substrate 2 | 0.012 | ||
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.012 | ||
| CD22 | CD22 molecule | 0.011 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.011 | ||
| PYCARD | PYD and CARD domain containing | 0.011 | ||
| GLUD2 | glutamate dehydrogenase 2 | 0.011 | ||
| STAB1 | stabilin 1 | 0.011 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.010 |